L-Dopa Pharmacokinetic Profile with Effervescent Melevodopa/Carbidopa versus Standard-Release Levodopa/Carbidopa Tablets in Parkinson’s Disease: A Randomised Study

Objectives. To characterize the pharmacokinetic profile of levodopa (L-dopa) and carbidopa after repeated doses of the effervescent tablet of melevodopa/carbidopa (V1512; Sirio) compared with standard-release L-dopa/carbidopa in patients with fluctuating Parkinson’s disease. Few studies assessed the...

Full description

Saved in:

Bibliographic Details
Main Authors:	Fabrizio Stocchi, Laura Vacca, Paola Grassini, Stephen Pawsey, Holly Whale, Stefano Marconi, Margherita Torti
Format:	Article
Language:	English
Published:	Wiley 2015-01-01
Series:	Parkinson's Disease
Online Access:	http://dx.doi.org/10.1155/2015/369465
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Patients with Advanced Parkinson’s Disease Receiving ≥2000 mg Daily Dose of Levodopa
by: Cindy Zadikoff, et al.
Published: (2020-01-01)

Carbidopa/levodopa dose elevation and safety concerns in Parkinson's patients: a cross-sectional and cohort design
by: Michael S Okun, et al.
Published: (2012-12-01)

Effect of Intestinal Levodopa-Carbidopa Infusion on Pharyngeal Dysphagia: Results from a Retrospective Pilot Study in Patients with Parkinson’s Disease
by: Bendix Labeit, et al.
Published: (2020-01-01)

Dosing Patterns during Conversion to IPX066, Extended-Release Carbidopa-Levodopa (ER CD-LD), in Parkinson’s Disease with Motor Fluctuations
by: John C. Morgan, et al.
Published: (2018-01-01)

Modified Carbon Nanotube Paste Electrode for Voltammetric Determination of Carbidopa, Folic Acid, and Tryptophan
by: Sakineh Esfandiari Baghbamidi, et al.
Published: (2012-01-01)

A Trihybrid Approach for Enhancing Crude Oil Recovery Using Effervescent‐Tablet‐Based Nanofluids
by: Naser Ali, et al.
Published: (2025-02-01)

Quail carcass quality with Pseudomonas putida bioemulsifier in effervescent tablet form through drinking water
by: Achmad Firman Maulana, et al.
Published: (2025-02-01)

Tablet characteristics and pharmacokinetics of orally disintegrating tablets containing coenzyme Q10 granules prepared by different methods
by: Kashiwagura Yasuharu, et al.
Published: (2023-03-01)

Cimetidine Pharmacodynamics and Pharmacokinetics in Healthy Subjects: A Comparison of Tablets and Suspension
by: ABR Thomson, et al.
Published: (1994-01-01)

Corticostriatal Plastic Changes in Experimental L-DOPA-Induced Dyskinesia
by: Veronica Ghiglieri, et al.
Published: (2012-01-01)

Clinical Aspects and Management of Levodopa-Induced Dyskinesia
by: Nicola Tambasco, et al.
Published: (2012-01-01)

l-Tyrosine and l-DOPA: Promising scaffolds for the synthesis of biologically active compounds
by: Ndayiragije, Euphrem, et al.
Published: (2024-11-01)

Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment
by: Katharina Bolsewig, et al.
Published: (2025-01-01)

Des professionnels qui s’agitent dans l’effervescence du Grand Paris
by: Hélène Dang Vu, et al.
Published: (2021-11-01)

Synergistic action of propolis with levodopa in the management of Parkinsonism in Drosophila melanogaster
by: Herbert Izo, Ninsiima, et al.
Published: (2020)

Somatosensory Evoked Potentials and Dopaminergic Responsiveness to Apomorphine and Levodopa in Parkinsonian Patients
by: M. Miranda, et al.
Published: (1996-01-01)

Levodopa Responsive Parkinsonism in Patients with Hemochromatosis: Case Presentation and Literature Review
by: Tarun Girotra, et al.
Published: (2017-01-01)

The Parkinson’s Disease Composite Scale Is Adequately Responsive to Acute Levodopa Challenge
by: Dávid Pintér, et al.
Published: (2019-01-01)

Clinical Features, Pathophysiology, and Treatment of Levodopa-Induced Dyskinesias in Parkinson’s Disease
by: J. Guridi, et al.
Published: (2012-01-01)

Effect of Grovth Medium on L-Dopa and Dopamine Production Using Citrobacter freundii (NRRL B-2643)
by: Sinan Saydam, et al.
Published: (2022-12-01)

Levetiracetam Ameliorates L-DOPA-Induced Dyskinesia in Hemiparkinsonian Rats Inducing Critical Molecular Changes in the Striatum
by: Huan Du, et al.
Published: (2015-01-01)

Role of Serotonin Neurons in L-DOPA- and Graft-Induced Dyskinesia in a Rat Model of Parkinson's Disease
by: Eunju Shin, et al.
Published: (2012-01-01)

Design and statistical optimization of an effervescent floating drug delivery system of theophylline using response surface methodology
by: Srikanth Meka Venkata, et al.
Published: (2016-03-01)

Preparation and in vitro characterization of non-effervescent floating drug delivery system of poorly soluble drug, carvedilol phosphate
by: Srikanth Meka Venkata, et al.
Published: (2014-12-01)

Rasagiline as Adjunct to Levodopa for Treatment of Parkinson’s Disease: A Systematic Review and Meta-Analysis
by: Osamu Kano, et al.
Published: (2022-01-01)

Zonisamide Enhances Motor Effects of Levodopa, Not of Apomorphine, in a Rat Model of Parkinson’s Disease
by: Haruo Nishijima, et al.
Published: (2018-01-01)

Sleep Quality and Levodopa Intestinal Gel Infusion in Parkinson’s Disease: A Pilot Study
by: Oriol De Fabregues, et al.
Published: (2018-01-01)

Compressibility of tableting materials and properties of tablets with glyceryl behenate
by: Mužíková Jitka, et al.
Published: (2015-03-01)

Formulation and Evaluation of Quality Parameters of Effervescent Granules from the Potent Antioxidant between Two Variants of the Adaptogenic Herb Ocimum tenuiflorum L.
by: Kalpana Parajuli-Baral
Published: (2023-01-01)

Wearable Sensors Measure Ankle Joint Changes of Patients with Parkinson’s Disease before and after Acute Levodopa Challenge
by: Zhuang Wu, et al.
Published: (2020-01-01)

The Harris Memorial Tablet
by: W. L. W. Field
Published: (1910-01-01)

Polyethylene oxide matrix tablet swelling evolution: The impact of molecular mass and tablet composition
by: Draksler Petra, et al.
Published: (2021-06-01)

Effects of Food on the Pharmacokinetics and Safety of HA121-28 Tablet, a Novel Multi-Targeting Tyrosine Kinase Inhibitor, in Healthy Chinese Subjects: A Phase I Clinical Trial
by: Liu Y, et al.
Published: (2025-01-01)

Avaliação da extração sólido-líquido de levodopa a partir de sementes de mucuna utilizando diferentes solventes
by: Rita de Cássia Superbi de Sousa, et al.
Published: (2024-02-01)

The Use of Spreadsheets for Pharmacokinetic Simulations
by: Joseph Chamberlain
Published: (2003-01-01)

Pharmacokinetic and pharmacodynamic data analysis : concepts and applications /
by: Gabrielsson, Johan
Published: (2016)

Population Pharmacokinetics of Vancomycin in Thai Patients
by: Tunggul Adi Purwonugroho, et al.
Published: (2012-01-01)

Determination of Acetyl Salicylic Acid in Aspirin tablets
by: Lana Mohammed Ali, et al.
Published: (2019-12-01)

Extractive Spectrophotometric Methods for the Determination of Etoricoxib in Tablets
by: Kamal Shah, et al.
Published: (2009-01-01)

Spectrophotometric Determination of Lamivudine in Pure and Tablet Forms
by: A. Biksham Babu, et al.
Published: (2012-01-01)